560 related articles for article (PubMed ID: 33189639)
1. Mesenchymal stem cell (MSC)-derived exosomes as a cell-free therapy for patients Infected with COVID-19: Real opportunities and range of promises.
Rezakhani L; Kelishadrokhi AF; Soleimanizadeh A; Rahmati S
Chem Phys Lipids; 2021 Jan; 234():105009. PubMed ID: 33189639
[TBL] [Abstract][Full Text] [Related]
2. Potential roles of mesenchymal stem cells and their exosomes in the treatment of COVID-19.
Cheng X; Jiang M; Long L; Meng J
Front Biosci (Landmark Ed); 2021 Oct; 26(10):948-961. PubMed ID: 34719217
[No Abstract] [Full Text] [Related]
3. Mesenchymal stem cell alongside exosomes as a novel cell-based therapy for COVID-19: A review study.
Dauletova M; Hafsan H; Mahhengam N; Zekiy AO; Ahmadi M; Siahmansouri H
Clin Immunol; 2021 May; 226():108712. PubMed ID: 33684527
[TBL] [Abstract][Full Text] [Related]
4. Potential application of mesenchymal stem cells and their exosomes in lung injury: an emerging therapeutic option for COVID-19 patients.
Al-Khawaga S; Abdelalim EM
Stem Cell Res Ther; 2020 Oct; 11(1):437. PubMed ID: 33059757
[TBL] [Abstract][Full Text] [Related]
5. Diverse Effects of Exosomes on COVID-19: A Perspective of Progress From Transmission to Therapeutic Developments.
Gurunathan S; Kang MH; Kim JH
Front Immunol; 2021; 12():716407. PubMed ID: 34394121
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stem cells and their derived exosomes to combat Covid-19.
Yousefi Dehbidi M; Goodarzi N; Azhdari MH; Doroudian M
Rev Med Virol; 2022 Mar; 32(2):e2281. PubMed ID: 34363275
[TBL] [Abstract][Full Text] [Related]
7. Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19.
Sengupta V; Sengupta S; Lazo A; Woods P; Nolan A; Bremer N
Stem Cells Dev; 2020 Jun; 29(12):747-754. PubMed ID: 32380908
[TBL] [Abstract][Full Text] [Related]
8. Exosomes, and the potential for exosome-based interventions against COVID-19.
Rahmani A; Soleymani A; Almukhtar M; Behzad Moghadam K; Vaziri Z; Hosein Tabar Kashi A; Adabi Firoozjah R; Jafari Tadi M; Zolfaghari Dehkharghani M; Valadi H; Moghadamnia AA; Gasser RB; Rostami A
Rev Med Virol; 2024 Jul; 34(4):e2562. PubMed ID: 38924213
[TBL] [Abstract][Full Text] [Related]
9. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.
Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA
Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777
[TBL] [Abstract][Full Text] [Related]
10. Potential therapeutic application of mesenchymal stem cell-derived exosomes in SARS-CoV-2 pneumonia.
Akbari A; Rezaie J
Stem Cell Res Ther; 2020 Aug; 11(1):356. PubMed ID: 32795359
[TBL] [Abstract][Full Text] [Related]
11. Stem cell-based and mesenchymal stem cell derivatives for coronavirus treatment.
Rafiee Z; Nejaddehbashi F; Nasrolahi A; Khademi Moghadam F
Biotechnol Appl Biochem; 2022 Oct; 69(5):1942-1965. PubMed ID: 34555225
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulatory effect of mesenchymal stem cells and mesenchymal stem-cell-derived exosomes for COVID-19 treatment.
Jayaramayya K; Mahalaxmi I; Subramaniam MD; Raj N; Dayem AA; Lim KM; Kim SJ; An JY; Lee Y; Choi Y; Raj A; Cho SG; Vellingiri B
BMB Rep; 2020 Aug; 53(8):400-412. PubMed ID: 32731913
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal Stem Cell Derived Exosomes: a Nano Platform for Therapeutics and Drug Delivery in Combating COVID-19.
Pinky ; Gupta S; Krishnakumar V; Sharma Y; Dinda AK; Mohanty S
Stem Cell Rev Rep; 2021 Feb; 17(1):33-43. PubMed ID: 32661867
[TBL] [Abstract][Full Text] [Related]
14. Challenges of mesenchymal stem cells in the clinical treatment of COVID-19.
Li L; Zhang X; Wu Y; Xing C; Du H
Cell Tissue Res; 2024 Jun; 396(3):293-312. PubMed ID: 38512548
[TBL] [Abstract][Full Text] [Related]
15. Stalling SARS-CoV2 infection with stem cells: can regenerating perinatal tissue mesenchymal stem cells offer a multi-tiered therapeutic approach to COVID-19?
Warrier S; Mohana Sundaram S; Varier L; Balasubramanian A
Placenta; 2022 Jan; 117():161-168. PubMed ID: 34915433
[TBL] [Abstract][Full Text] [Related]
16. Hypothesis for the management and treatment of the COVID-19-induced acute respiratory distress syndrome and lung injury using mesenchymal stem cell-derived exosomes.
Taghavi-Farahabadi M; Mahmoudi M; Soudi S; Hashemi SM
Med Hypotheses; 2020 Nov; 144():109865. PubMed ID: 32562911
[TBL] [Abstract][Full Text] [Related]
17. Rationale for the Use of Radiation-Activated Mesenchymal Stromal/Stem Cells in Acute Respiratory Distress Syndrome.
Tovar I; Guerrero R; López-Peñalver JJ; Expósito J; Ruiz de Almodóvar JM
Cells; 2020 Sep; 9(9):. PubMed ID: 32887260
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal Stem Cell-Based Therapy as an Alternative to the Treatment of Acute Respiratory Distress Syndrome: Current Evidence and Future Perspectives.
Fernández-Francos S; Eiro N; González-Galiano N; Vizoso FJ
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360616
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal Stem Cell-Derived Exosomes Exhibit Promising Potential for Treating SARS-CoV-2-Infected Patients.
Raghav A; Khan ZA; Upadhayay VK; Tripathi P; Gautam KA; Mishra BK; Ahmad J; Jeong GB
Cells; 2021 Mar; 10(3):. PubMed ID: 33799966
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal Stromal Cell-Based Therapy: A Promising Approach for Severe COVID-19.
Xiong J; Chen L; Zhang L; Bao L; Shi Y
Cell Transplant; 2021; 30():963689721995455. PubMed ID: 33650894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
